Search

Search Constraints

You searched for: Author/Creator Mous, R.

Search Results

3. P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BTK DEGRADER, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES. (23rd June 2022)